MHC Class 1 and PDL-1 Status of Primary Tumor and Lymph Node Metastatic Tumor Tissue in Gastric Cancers

The prognosis of metastatic gastric cancer is poor. Despite the use of VEGF-, EGFR-, and HER2-targeting agents, prognosis is still poor in advanced gastric cancer. Although cancer immunotherapy responds well in some patients, clinical use is limited due to unanswered patients. For this reason, it is...

Descripción completa

Detalles Bibliográficos
Autor principal: Erdogdu, Ibrahim Halil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381579/
https://www.ncbi.nlm.nih.gov/pubmed/30881447
http://dx.doi.org/10.1155/2019/4785098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381579/
https://www.ncbi.nlm.nih.gov/pubmed/30881447
http://dx.doi.org/10.1155/2019/4785098

Ejemplares similares